Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2617–2640 of 26,669 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CTRL Clear all

Conditions: Non-Alcoholic Steatohepatitis
Interventions: Protandim, Placebo; Dietary Supplement
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Aptensio XR, Placebo; Drug
Lead sponsor: Rhodes Pharmaceuticals, L.P.; Industry
Eligibility: 4 Years to 6 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Las Vegas, Nevada • Durham, North Carolina

Conditions: Cardiac Surgery
Interventions: Remote Ischemic Preconditioning, Sham; Procedure
Lead sponsor: McMaster University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Portland, Maine • Winston-Salem, North Carolina

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Sorafenib (Nexavar, BAY43-9006), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 703 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 3
States / cities: Fayetteville, Arkansas • Stanford, California • Philadelphia, Pennsylvania

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Pamrevlumab, Placebo; Drug
Lead sponsor: Kyntra Bio; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 393 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 60
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 50 more

Conditions: Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases, Hormones, Pituitary Diseases
Interventions: Once weekly subcutaneous injection of TransCon hGH, Once daily subcutaneous injection of Genotropin; Drug
Lead sponsor: Ascendis Pharma Endocrinology Division A/S; Industry
Eligibility: 3 Years to 12 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 16
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 13 more

Conditions: Kidney Disease
Interventions: Mezagitamab, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 347 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 45
States / cities: Birmingham, Alabama • Montgomery, Alabama • Surprise, Arizona + 38 more

Conditions: Chronic Insomnia, Sleep Deprivation, REM Behavior Disorder, REM Sleep Behavior Disorder, REM Sleep Measurement, Insomnia, Insomnia Related to Specified Disorder, Insomnia Due to Other Mental Disorder, Insomnia Comorbid to Psychiatric Disorder, Insomnia Due to Anxiety and Fear, Insomnia Related to Another Mental Condition, Insomnia Disorders, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, Post Trauma Nightmares, PTSD - Post Traumatic Stress Disorder, Sleep Quality, Anesthesia, Anxiety, Depression, Mental Health, Alzheimer Disease or Associated Disorder, Parkinsons, Circadian Rhythm, Circadian Dysregulation, PTSD, Post-Traumatic, Post-Traumatic Stress Disorder Complex, Military Combat Stress Reaction, Sleep, Military Activity, Veterans, Shift Work Sleep Disorder, Menopause Related Conditions, Pain, Cancer Pain, Athletes
Interventions: PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca, Continuous EEG Monitoring; Procedure · Drug · Device
Lead sponsor: Nyree Penn; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Aventura, Florida

Conditions: Cognitive Dysfunction, Memory Impairment
Interventions: Donepezil 5 mg, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 278
States / cities: Anaheim, California • Antioch, California • Baldwin Park, California + 206 more

Conditions: Ventilated Patient in Intensive Care
Interventions: Weighted blanket, Standard hospital linens; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Uterine Prolapse
Interventions: sacral colpopexy; Procedure
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Facial Aging, Rejuvenation, Stem Cell, Stem Cell Banking
Interventions: Autologous Hair Follicle-Derived Secretome, Control Saline; Other
Lead sponsor: Acorn Biolabs Inc.; Industry
Eligibility: 30 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Acute Lung Injury, Adult Respiratory Distress Syndrome
Interventions: Low-tidal-volume ventilation, Airway Pressure Release Ventilation (APRV); Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Neuropathic Pain
Interventions: GW493838; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 32
States / cities: Huntsville, Alabama • Hot Springs, Arizona • Little Rock, Arkansas + 28 more

Conditions: Kidney Failure, Chronic Therapy; Hemodialysis
Interventions: soluble ferric pyrophosphate, Placebo; Drug
Lead sponsor: Rockwell Medical Technologies, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Kalamazoo, Michigan

Conditions: Pharmacokinetics
Interventions: Lurasidone 40 mg, Placebo 40 mg, Ortho Tri-Cyclen; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: San Diego, California

Conditions: Obesity Complicating Childbirth
Interventions: Ultrasound Examination, Antenatal Testing (biophysical profile); Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Meniere Disease
Interventions: Mastoid Oscillator, Control Device; Device
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Rochester, New York

Conditions: GIST With D842V Mutated PDGFRA Gene
Interventions: Crenolanib, Placebo; Drug
Lead sponsor: Arog Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 6
States / cities: Santa Monica, California • Miami, Florida • Durham, North Carolina + 3 more

Conditions: Weight Loss
Interventions: Shared Medical Visits, Full Plate Living; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Low-back Pain, Anxiety, Depression
Interventions: EaseVRx, Sham VR; Device
Lead sponsor: AppliedVR Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 1,093 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Van Nuys, California

Conditions: Schizophrenia
Interventions: Narrative Enhancement and Cognitive Therapy, Supportive Group Therapy; Behavioral
Lead sponsor: John Jay College of Criminal Justice, City University of New York; Other
Eligibility: 21 Years to 65 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension
Interventions: Geneticure Panel for HTN therapy, JNC-8; Drug
Lead sponsor: Geneticure, LLC; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 15
States / cities: Andover, Minnesota • Blaine, Minnesota • Bloomington, Minnesota + 12 more

Conditions: Rosacea
Interventions: PDI-320, PDI-320 Monad #1, PDI-320 Monad #2, Vehicle; Drug
Lead sponsor: PreCision Dermatology, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: San Diego, California • Albuquerque, New Mexico

Search by objective public record fields.

The Effect of Protandim on Non-alcoholic Steatohepatitis

A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD

Remote Ischemic Preconditioning in Cardiac Surgery Trial

A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil

Weighted Blanket to Improve Sedation and Comfort During Ventilator Weaning

Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy

Secretome Treatment for Facial Rejuvenation

Acute Lung Injury Ventilator Evaluation (ALIVE)

The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain

A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.

A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

Weekly Antepartum Testing in Women With BMI 30-40 and Neonatal Outcomes

A Study of a Mastoid Device in Subjects With Ménière's Disease

Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST

Food is Medicine: Pilot Study

EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain

Trial of Treatment for Internalized Stigma in Schizophrenia

Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea